Trials / Withdrawn
WithdrawnNCT01974973
Stem Cell Therapy in Autism Spectrum Disorders
Open Label Study of Autologous Bone Marrow Mononuclear Cells in Autism Spectrum Disorders
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neurogen Brain and Spine Institute · Academic / Other
- Sex
- All
- Age
- 6 Months – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to study the effect of stem cell therapy on common symptoms in patients with autism spectrum disorders
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Autologous bone marrow mononuclear cell transplantation | Intrathecal autologous bone marrow mononuclear cell transplantation |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2016-01-01
- Completion
- 2016-05-01
- First posted
- 2013-11-04
- Last updated
- 2018-10-25
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT01974973. Inclusion in this directory is not an endorsement.